Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment

Study ID: NCT06978062
Start Date: 2026-02-20
End Date: 2029-09-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

27

Intervention / Treatment

Bemarituzumab

Nice

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Source: clinicaltrials.gov

Share:
Add to list

The Importance of Anesthesia Method in Fragile Patients

Study ID: NCT07191769
Start Date: 2025-10-01
End Date: 2026-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

general anaesthesia

regional anaesthesia

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Source: clinicaltrials.gov

Share:
Add to list

ESD in Locally Advanced Rectal Cancer Following CRT

Study ID: NCT07192627
Start Date: 2025-10-01
End Date: 2028-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Endoscopic mucosal dissection

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Epigenetic Optimization Through Biofrequency Nutrition

Study ID: NCT07093242
Start Date: 2025-10-01
End Date: 2026-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Personalized Nutritional Follow-Up

Sponsor

University of Almeria

Source: clinicaltrials.gov

Share:
Add to list

Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program

Study ID: NCT07129369
Start Date: 2026-01-02
End Date: 2028-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

186

Intervention / Treatment

PASIM PROGRAM

Psychoeducation

Usual-Care-only

Sponsor

Chinese University of Hong Kong

Source: clinicaltrials.gov

Share:
Add to list

Physician Engagement in EMS Transport Refusal Rates

Study ID: NCT07107737
Start Date: 2025-10
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

Physician Consultation

Standard of Care

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences

Study ID: NCT07111234
Start Date: 2025-09-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Carbon Monoxide Measurement

Nicotine Oral Pouch

Administration questionnaire

Smoke usual brand cigarette

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Effect of Noninvasive Ventilation on Physical Activity and Inflammation in COPD Patients

Study ID: NCT01037387
Start Date: 2025-12
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

50

Intervention / Treatment

Control

NIMV group

Sponsor

La Paz University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Study ID: NCT07157514
Start Date: 2026-01
End Date: 2034-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

306

Intervention / Treatment

131i-Apamistamab

Fludarabine

Cyclophosphamide

Total Body Irradiation (TBI)

Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Sponsor

Actinium Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

Study ID: NCT07032714
Start Date: 2025-12-16
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

25

Intervention / Treatment

Talkqueamab

Mezigdomide

Dexamethasone

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list